Owens & Minor Expects 2025 Revenues Of $10.85B-$11.15B And Adjusted EPS Of $1.60-$1.85 Versus Consensus Of $10.97B And $1.79, Respectively

Benzinga
28 Feb

2025 Financial Outlook

The Company issued its outlook for 2025; summarized below:

  • Revenue for 2025 to be in a range of $10.85 billion to $11.15 billion
  • Adjusted EBITDA for 2025 to be in a range of $560 million to $590 million
  • Adjusted EPS for 2025 to be in a range of $1.60 to $1.85

The Company's outlook for 2025 excludes any impact of the previously announced Rotech acquisition, any potential transaction involving the Products & Healthcare Services segment, or share repurchase activity, and contains assumptions, including current expectations regarding the impact of general economic conditions.

Key assumptions supporting the Company's 2025 financial guidance include:

  • Gross margin of 20.75% to 21.25%
  • Interest expense of $138 million to $142 million
  • Adjusted effective tax rate of 29.0% to 30.0%
  • Diluted weighted average shares of ~80 million
  • Capital expenditures, gross, of $250 million to $270 million
  • Stable commodity prices
  • FX rates as of 12/31/2024

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10